Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

A woman with lupus had blood cell destruction, treated successfully with medication.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

Blocking α1-integrin makes adult fibroblasts more like foetal ones, improving their movement and aiding wound healing.

People with celiac disease have a higher risk of developing alopecia areata.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Early hair loss may predict heart disease.

Adalimumab may cause severe hair loss in some patients.

TNF-a may not be as involved in certain types of hair loss as previously thought.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Eosinophils are not a reliable marker for diagnosing alopecia areata.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Hair loss might be linked to eye aging due to inflammation markers in blood.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

The woman has a skin condition involving nodules, scars, and hair loss.

Targeting Vδ1+T-cells may help treat alopecia areata.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.